ALKSV — Alkermes Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeLarge CapNeutral

Annual cashflow statement for Alkermes, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-139	-197	-111	-48.2	-158
Depreciation
Deferred Taxes
Non-Cash Items	132	123	88.7	91.7	122
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-7.42	65.4	13.1	-25.5	12.7
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities	99.3	72.1	82.8	102	21
Capital Expenditures	-69.4	-90.9	-42.2	-28	-38.3
Purchase of Fixed Assets
Other Investing Cash Flow Items	47.2	-50.9	30.7	-38.2	-26.3
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-22.2	-142	-11.5	-66.2	-64.5
Financing Cash Flow Items	-19.6	-9.32	-7.7	-16.6	-18.2
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-1.62	6.76	-2.17	29.1	-1.57
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	75.5	-63	69.2	64.6	-45.1